Pharma-Bio Serv (PBSV) Liabilities from Discontinued Operations (2017)
Pharma-Bio Serv's (PBSV) quarterly Liabilities from Discontinued Operations came in at $110206.0 in Q4 2017.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Liabilities from Discontinued Operations (2017) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Liabilities from Discontinued Operations for 1 consecutive years, with $110206.0 the latest figure, recorded in Q4 2017.
- For the quarter ending Q4 2017, Liabilities from Discontinued Operations changed N/A year-over-year to $110206.0; the trailing twelve-month figure through Oct 2017 stood at $110206.0 (changed N/A YoY), and the FY2017 full-year result was $110206.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at $110206.0 in Q4 2017 per PBSV's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at $110206.0 in Q4 2017 and bottomed at $110206.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 |